TipRanks
Advertisement
Advertisement
First Tracks Biotherapeutics reports Q2 EPS (95c), consensus (80c)
PremiumThe FlyFirst Tracks Biotherapeutics reports Q2 EPS (95c), consensus (80c)
2M ago
First Tracks Biotherapeutics price target raised to $65 from $48 at Barclays
Premium
The Fly
First Tracks Biotherapeutics price target raised to $65 from $48 at Barclays
2M ago
First Tracks price target raised to $57 from $44 at H.C. Wainwright
Premium
The Fly
First Tracks price target raised to $57 from $44 at H.C. Wainwright
2M ago
First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
PremiumThe FlyFirst Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
2M ago
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
Premium
Ratings
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
2M ago
After Forte acquisition, H.C. Wainwright says First Tracks could be target
Premium
The Fly
After Forte acquisition, H.C. Wainwright says First Tracks could be target
2M ago
Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway
PremiumRatingsEmily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway
5M ago
Two new option listings and one option delisting on May 11th
Premium
The Fly
Two new option listings and one option delisting on May 11th
5M ago
First Tracks Biotherapeutics files to sell 10.5M shares of common for holders
Premium
The Fly
First Tracks Biotherapeutics files to sell 10.5M shares of common for holders
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―